EQNVX
Price
$24.13
Change
+$0.14 (+0.58%)
Updated
Nov 26 closing price
Net Assets
690.11M
RWEBX
Price
$67.88
Change
+$0.53 (+0.79%)
Updated
Nov 26 closing price
Net Assets
209.02B
Interact to see
Advertisement

EQNVX vs RWEBX

Header iconEQNVX vs RWEBX Comparison
Open Charts EQNVX vs RWEBXBanner chart's image
MFS Equity Income R6
Price$24.13
Change+$0.14 (+0.58%)
VolumeN/A
Net Assets690.11M
American Funds Washington Mutual R2E
Price$67.88
Change+$0.53 (+0.79%)
VolumeN/A
Net Assets209.02B
EQNVX vs RWEBX Comparison Chart in %
View a ticker or compare two or three
VS
EQNVX vs. RWEBX commentary
Nov 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EQNVX is a StrongBuy and RWEBX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RWEBX has more cash in the bank: 209B vs. EQNVX (690M). EQNVX pays higher dividends than RWEBX: EQNVX (2.16) vs RWEBX (0.76). EQNVX was incepted earlier than RWEBX: EQNVX (13 years) vs RWEBX (11 years). RWEBX (1.06) is less costly to investors than EQNVX (0.63). EQNVX is a more actively managed with annual turnover of: 40.00 vs. RWEBX (29.00). EQNVX has a lower initial minimum investment than RWEBX: EQNVX (0) vs RWEBX (250). EQNVX annual gain was more profitable for investors over the last year : 6.48 vs. RWEBX (4.54). EQNVX return over 5 years is better than : 51.66 vs. RWEBX (42.06).
EQNVXRWEBXEQNVX / RWEBX
Total Expense Ratio0.551.0652%
Annual Report Gross Expense Ratio0.631.0659%
Fund Existence13 years11 years-
Gain YTD15.85311.645136%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets690M209B0%
Annual Yield % from dividends2.160.76286%
Returns for 1 year6.484.54143%
Returns for 3 years32.2728.76112%
Returns for 5 years51.6642.06123%
Returns for 10 years115.1772.25159%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
INKT11.450.54
+4.95%
MiNK Therapeutics Inc
CAE26.450.56
+2.16%
CAE
SCM12.240.24
+2.00%
STELLUS CAPITAL INVESTMENT Corp
EFXT13.790.06
+0.44%
Enerflex Ltd
DRDBU10.94N/A
N/A
Roman DBDR Acquisition Corp. II